Innovation Pharmaceuticals Inc (IPIX)

[steelyeye]

One may as well ask why the SP is nearly 5 cents when it was .015 just a few weeks ago? That's a large % increase during no "substantial" news.

No one knows the exact catalysts to drive the SP in the future, either, but apparently there is a IPIX business development director on board, and a completed provider/payer analysis for B-OM. That single indication is one of three successful PH-2 clinical trials using Brilacidin.

No one knows why Kips suddenly decided to file their share conversion and/or purchase in early July, except that June 30 is "end of year." Which makes one wonder about this:

...partnerships usually require all warrants issued to be converted and monies owed to be reimbursed. If that occurred over the last 12 months and June 30th is the end of year for innovative, then there is a dot to connect. The idea is to have clean books within negotiations.

No one knows why Leo spent half the company kitty, 4 million, on Israeli medical lasers, either. Did he have a deal in the works? Was it pure whimsy?

Maybe it's just me, but I doubt Leo is happily sunning himself poolside, only trying to insure his paycheck keeps arriving, which, as many know, is the oldest and tiredest and most widely used argument against CEO's on the OTC... and likely applicable to about a third at most. Sometimes indicated by small companies with OS in the billions.

In response to

What is the catalyst that will jump us 10x and then what is the catalyst that gets us a buyout for 12x